8-K current report · filed Jun 12, 2026

Praxis Precision Medicines, Inc. (PRAX) 8-K Current Report: June 12, 2026

Item 5.07PRAX overview

Short answer

Praxis Precision Medicines, Inc. (PRAX) filed an 8-K current report with the SEC on June 12, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders elected Gregory Norden, Marcio Souza and William Young as Class III directors through the 2029 annual meeting.

Praxis Precision Medicines, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.07 · Submission of Matters to a Vote of Security Holders

  • Stockholders elected Gregory Norden, Marcio Souza and William Young as Class III directors through the 2029 annual meeting
  • William Young received 21,293,535 votes for and 3,614,729 withheld, indicating comparatively weaker shareholder support
  • Ernst & Young LLP ratified as independent auditor for fiscal 2026 with 26,667,376 votes for and 39,285 against
  • Advisory executive compensation proposal approved with 24,054,017 votes for and 824,318 against
  • Director elections and compensation approval support board continuity and management’s current pay structure; compensation vote remains non-binding

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Praxis Precision Medicines, Inc. 8-K filings

Get the next PRAX 8-K as it lands

Follow PRAX for push alerts, or ask the research agent what this filing means.